The University of Health Network (UHN) will be carrying out a study in association with Shoppers Drug Mart in order to analyze the efficiency of blockchain implementation in seed-to-sale tracking of Medical Cannabis products.
Trials will allow patients to select medical cannabis products from a blockchain-secured base that allows them to know the exact characteristics of each product. It also provides physicians the opportunity to get in deep information about the plant’s profile, THC and terpene levels.
“Shoppers is the largest pharmacy chain in Canada, and we have always been at the vanguard of helping people live healthy lives," Ken Weisbrod, VP of Toronto-based Shoppers told Benzinga. "This new initiative, which is part of a clinical trial led by one of the most prestigious hospitals in the country, is a critical step in making sure that patients are receiving the right therapies in the right dosages at the right times."
The service was developed by Shoppers and TruTrace Technologies TTT BKKSF. The licensed partners that will supply medical cannabis — dried flower, extracts, edibles, and topicals — are Zenabis Global, WeedMD Rx, The Valens Company, Radient Technologies, Organigram Holdings, MediPharm Labs, The Flowr Corporation, Dosecann Cannabis Solutions, CanniMed, Avicanna, Aurora and Aphria.
“The challenge with the medical use of cannabis is that physicians and patients are unsure of the quality of products being consumed,” says Dr. Hance Clarke, who heads up the UHN. “For the first time, we have a national repository of data that can provide answers about the effectiveness of these products and to test their claims. We need the evidence to help us in prescribing the appropriate validated product, at the right dose, for the right patient. Ensuring quality standards will allow physicians and their patients to be confident about using medical cannabis to treat a wide range of pain-related ailments.”
TruTrace CEO Robert Galarza told Benzinga that when it comes to distributing any medication, quality and consistency are critical.
"Unfortunately, this has been very difficult to track when it comes to cannabis-based therapies," Galarza said. "We are excited to be working with Shoppers to help ensure that thousands of Canadians who use prescription cannabis are getting the correct dosages and accurate information about their medicines.”
Photo courtesy of Unsplash
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Meet the biggest cannabis industry players and make deals that will push the industry forward.
Featuring live company presentations, insider panels, and unmatched access to networking, the Benzinga Cannabis Capital Conference is where cannabis executives and entrepreneurs meet.
Join us April 11-12, 2023 at Fontainebleau Miami Beach in sunny Florida.